Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Multifunctional APJ Pathway Promotes Ovarian Cancer Progression and Metastasis.

Neelakantan D, Dogra S, Devapatla B, Jaiprasart P, Mukashyaka MC, Janknecht R, Dwivedi SKD, Bhattacharya R, Husain S, Ding K, Woo S.

Mol Cancer Res. 2019 Jun;17(6):1378-1390. doi: 10.1158/1541-7786.MCR-18-0989. Epub 2019 Mar 11.

PMID:
30858172
2.

Publisher Correction: EMT cells increase breast cancer metastasis via paracrine GLI activation in neighbouring tumour cells.

Neelakantan D, Zhou H, Oliphant MUJ, Zhang X, Simon LM, Henke DM, Shaw CA, Wu MF, Hilsenbeck SG, White LD, Lewis MT, Ford HL.

Nat Commun. 2018 Nov 12;9(1):4720. doi: 10.1038/s41467-018-07168-z.

3.

EMT cells increase breast cancer metastasis via paracrine GLI activation in neighbouring tumour cells.

Neelakantan D, Zhou H, Oliphant MUJ, Zhang X, Simon LM, Henke DM, Shaw CA, Wu MF, Hilsenbeck SG, White LD, Lewis MT, Ford HL.

Nat Commun. 2017 Jun 12;8:15773. doi: 10.1038/ncomms15773. Erratum in: Nat Commun. 2018 Nov 12;9(1):4720.

4.

CD147: a small molecule transporter ancillary protein at the crossroad of multiple hallmarks of cancer and metabolic reprogramming.

Kendrick AA, Schafer J, Dzieciatkowska M, Nemkov T, D'Alessandro A, Neelakantan D, Ford HL, Pearson CG, Weekes CD, Hansen KC, Eisenmesser EZ.

Oncotarget. 2017 Jan 24;8(4):6742-6762. doi: 10.18632/oncotarget.14272.

5.

Clonal cooperativity in heterogenous cancers.

Zhou H, Neelakantan D, Ford HL.

Semin Cell Dev Biol. 2017 Apr;64:79-89. doi: 10.1016/j.semcdb.2016.08.028. Epub 2016 Aug 28. Review.

6.

TWIST1-Induced miR-424 Reversibly Drives Mesenchymal Programming while Inhibiting Tumor Initiation.

Drasin DJ, Guarnieri AL, Neelakantan D, Kim J, Cabrera JH, Wang CA, Zaberezhnyy V, Gasparini P, Cascione L, Huebner K, Tan AC, Ford HL.

Cancer Res. 2015 May 1;75(9):1908-21. doi: 10.1158/0008-5472.CAN-14-2394. Epub 2015 Feb 25.

7.

Intratumoral heterogeneity: Clonal cooperation in epithelial-to-mesenchymal transition and metastasis.

Neelakantan D, Drasin DJ, Ford HL.

Cell Adh Migr. 2015;9(4):265-76. doi: 10.4161/19336918.2014.972761. Epub 2014 Oct 16. Review.

8.

The management of endometrial hyperplasia: an evaluation of current practice.

Clark TJ, Neelakantan D, Gupta JK.

Eur J Obstet Gynecol Reprod Biol. 2006 Apr 1;125(2):259-64. Epub 2005 Oct 24.

PMID:
16246481
9.

Quality of life instruments in studies of chronic pelvic pain: a systematic review.

Neelakantan D, Omojole F, Clark TJ, Gupta JK, Khan KS.

J Obstet Gynaecol. 2004 Nov;24(8):851-8. Review.

PMID:
16147635
10.

Role of rescue IVF-ET treatment in the management of high response in stimulated IUI cycles.

Olufowobi O, Sharif K, Papaioannou S, Mohamed H, Neelakantan D, Afnan M.

J Obstet Gynaecol. 2005 Feb;25(2):166-8.

PMID:
15814397
11.

Are the anticipated benefits of myomectomy achieved in women of reproductive age? A 5-year review of the results at a UK tertiary hospital.

Olufowobi O, Sharif K, Papaionnou S, Neelakantan D, Mohammed H, Afnan M.

J Obstet Gynaecol. 2004 Jun;24(4):434-40.

PMID:
15203587
12.

Planned vaginal delivery versus elective caesarean section: a study of 705 singleton term breech presentations.

Gupta E, Neelakantan D, Dwarakanath LS, Gee H.

BJOG. 2000 Aug;107(8):1058. No abstract available.

Supplemental Content

Loading ...
Support Center